Introducing DAVAMED™ C1: the Multi-Functional Excipient with Unmatched Quality Assurance

DAVAMED™ C1 is a premium starch excipient designed specifically for direct compression in tablet manufacturing. It is a partially pregelatinized corn starch developed through advanced processing techniques to deliver superior functionality in pharmaceutical formulations and manufactured under strict GMP standards and compliant with major pharmacopeias such as USP/EP/ IP/ BP standards. 

DAVAMED™ C1 boasts a unique combination of properties:
  • Free-Flowing Powder: Ensures smooth handling during production.
  • Exceptional Binding Capacity: Creates strong, consistent tablets.
  • Excellent Disintegration: Guarantees rapid drug release for optimal efficacy.

It can be seamlessly substituted for more expensive microcrystalline cellulose (MCC), leading to significant cost savings without compromising quality. Additionally, DAVAMED™ C1 improves production by being perfectly suited for direct compression and hard capsule filling, eliminating the need for complex granulation processes.

But what truly sets DAVAMED™ C1 apart is its unwavering commitment to quality. 

DAVAMED™ C1 is supported by a Drug Master File (DMF) filed with the U.S. Food and Drug Administration (USFDA), demonstrating full transparency and comprehensive documentation of our manufacturing process. In addition, it holds EXCiPACT certification—an internationally recognized standard verifying that our GMP and GDP systems meet the stringent requirements of pharmaceutical manufacturers.

Earning these certifications reflects our unwavering dedication to the highest quality standards. They enable our partners to confidently integrate DAVAMED™ C1 into their formulations, assured that it has undergone rigorous evaluation by leading regulatory authorities.

This comprehensive filing details every facet of DAVAMED™ C1's production, from the raw materials used to the rigorous quality control measures in place.

Key Benefits of DAVAMED™ C1

  • Exceptional Flowability Ensures smooth powder flow during tablet manufacturing, reducing the risk of processing delays and equipment wear.
  • Superior Binding Capacity Provides excellent tablet hardness and durability, allowing for consistent production of strong, uniform tablets.
  • Efficient Disintegration Enables rapid and reliable disintegration, ensuring timely release of active ingredients for enhanced bioavailability.
  • Versatility Adaptable to various formulations and tablet sizes, making it ideal for a wide range of pharmaceutical applications.

Contact info@smscor.com today to learn more about how DAVAMED™ C1 can revolutionize your tablet production and elevate your commitment to patient safety 

DRAG